BARINTHUS
LIVE

Serial Number

79392428

Owner

Barinthus Biotherapeutics (UK) Limited

Attorney

Eric Lamb

Filing Date

Jan 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BARINTHUS Trademark

Serial Number: 79392428 • Registration: 7772720

BARINTHUS is a trademark filed by Barinthus Biotherapeutics (UK) Limited on January 8, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Barinthus Biotherapeutics (UK) Limited (3 trademarks)

Units 6-10, The Zeus Building,

Entity Type: 99

Trademark Details

Filing Date

January 8, 2024

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

pharmaceutical substances for the treatment of cancer, infectious diseases, and autoimmune diseases; pharmaceutical substances for the prevention of cancer, infectious diseases, and autoimmune diseases; pharmaceutical preparations for the treatment of cancer, infectious diseases, and autoimmune diseases; pharmaceutical preparations for the prevention of cancer, infectious diseases, and autoimmune diseases; pharmaceutical products for the treatment of cancer, infectious diseases, and autoimmune diseases; pharmaceutical products for the prevention of cancer, infectious diseases, and autoimmune diseases; pharmaceutical substances, pharmaceutical preparations and pharmaceutical products for the induction of immune tolerance, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunotherapeutics, namely, pharmaceutical products for the treatment of cancer and infectious diseases, and autoimmune diseases; immunotherapeutics, namely, pharmaceutical products for the prevention of cancer and infectious diseases, and autoimmune diseases; vaccines; viral vaccines; vaccines for prevention against influenza; therapeutic vaccines for the treatment of influenza; vaccines for prevention against infectious diseases; therapeutic vaccines for the treatment of infectious diseases; vaccines for prevention against cancer; therapeutic vaccines for the treatment of cancer; viral antigens in the nature of biological tissue cultures for medical purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 19, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 19, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 27, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 29, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2025 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 13, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 13, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 13, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 13, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 13, 2025 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2025 TROA
REFUSAL PROCESSED BY IB
Sep 1, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 15, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 15, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 6, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 5, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 2, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 28, 2024 REPR